Start your Trading & Investing Journey with us
Join our channel for Daily Free Trades with Live analysis on Youtube, Trade Setup with Important Levels, and Important Stock Market Updates
Ravelcare IPO Review - Issue Date, Price, GMP, Subscription, Allotment, Lot Size, and Details
Ravelcare IPO Review
Ravelcare Limited operates in India’s beauty and personal care (BPC) segment through a digital-first, direct-to-consumer model. It earns revenue primarily by selling haircare, skincare, bodycare and scalpcare products through its website, e-commerce marketplaces and quick-commerce platforms. The company focuses on personalized and concern-specific formulations developed using customer data. Its products address hair fall, frizz, dryness, acne, pigmentation and other skin-and-hair-related concerns.
The Company is led by Promoter, i.e., AYUSH MAHESH VARMA, MAHESHKUMAR RAMCHANDRA VARMA AND ANITA MAHESH VARMA
The Revenues from operations for the Period ended on Sep 30 2025 and Fiscals ended on Mar 31, 2025, 2024 and 2023 were ₹1,444.38 Lakh, ₹2,529.80 Lakh, ₹2,227.88 Lakh, and ₹349.37 Lakh, The EBITDA for the Period ended on Sep 30 2025, 2025 and Fiscals ended on Mar 31, 2025, 2024 and 2023 were ₹432.65 Lakh, ₹681.98 Lakh, ₹664.11 Lakh, and ₹50.70 Lakh, The Profit after Tax for the Period ended on Sep 30 2025, 2025 and Fiscals ended on Mar 31, 2025, 2024 and 2023 were were ₹319.59 Lakh, ₹525.52 Lakh, ₹502.41 Lakh, and ₹41.47 Lakh, respectively. This indicates a steady growth in financial performance.
The Company Key Performance Indicates the pre-issue EPS of ₹10.5 and post-issue EPS of ₹7.66 for FY25. The pre-issue P/E ratio is 12.38x,while the post-issue P/E ratio is 16.97x against the Industry P/E ratio is NA The company's ROE for FY25 is 68.04% and RoNW is 50.77% The Annualised EPS is ₹9.32x and P/E is
13.95x. These metrics suggest that the IPO is Fairly priced.
The Grey Market Premium (GMP) of Ravelcare showing listing gains of
23.07%.Given the company's financial performance and the valuation of the IPO, we recommend Risky Investors to Apply to the Ravelcare Limited IPO for Listing gain.





